These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38099569)

  • 1. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
    Fisher AD; Ristori J; Romani A; Cassioli E; Mazzoli F; Cocchetti C; Pierdominici M; Marconi M; Ricca V; Maggi M; Vignozzi L; Castellini G
    J Clin Endocrinol Metab; 2024 May; 109(6):1565-1579. PubMed ID: 38099569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.
    de Vries AL; Steensma TD; Doreleijers TA; Cohen-Kettenis PT
    J Sex Med; 2011 Aug; 8(8):2276-83. PubMed ID: 20646177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
    van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
    J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puberty suppression in gender identity disorder: the Amsterdam experience.
    Kreukels BP; Cohen-Kettenis PT
    Nat Rev Endocrinol; 2011 May; 7(8):466-72. PubMed ID: 21587245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
    Costa R; Dunsford M; Skagerberg E; Holt V; Carmichael P; Colizzi M
    J Sex Med; 2015 Nov; 12(11):2206-14. PubMed ID: 26556015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents.
    Schagen SE; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
    J Sex Med; 2016 Jul; 13(7):1125-32. PubMed ID: 27318023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria.
    Klink D; Caris M; Heijboer A; van Trotsenburg M; Rotteveel J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E270-5. PubMed ID: 25427144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
    Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
    JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
    van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
    J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young adult psychological outcome after puberty suppression and gender reassignment.
    de Vries AL; McGuire JK; Steensma TD; Wagenaar EC; Doreleijers TA; Cohen-Kettenis PT
    Pediatrics; 2014 Oct; 134(4):696-704. PubMed ID: 25201798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puberty suppression in adolescents with gender dysphoria: an emerging issue with multiple implications.
    Betsi G; Goulia P; Sandhu S; Xekouki P
    Front Endocrinol (Lausanne); 2024; 15():1309904. PubMed ID: 38988996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
    van der Loos MATC; Hannema SE; Klink DT; den Heijer M; Wiepjes CM
    Lancet Child Adolesc Health; 2022 Dec; 6(12):869-875. PubMed ID: 36273487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review: Puberty suppression with GnRH analogues in adolescents with gender incongruity.
    Ramos GGF; Mengai ACS; Daltro CAT; Cutrim PT; Zlotnik E; Beck APA
    J Endocrinol Invest; 2021 Jun; 44(6):1151-1158. PubMed ID: 33111215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time Course of Body Composition Changes in Transgender Adolescents During Puberty Suppression and Sex Hormone Treatment.
    Boogers LS; Reijtenbagh SJP; Wiepjes CM; van Trotsenburg ASP; den Heijer M; Hannema SE
    J Clin Endocrinol Metab; 2024 Jul; 109(8):e1593-e1601. PubMed ID: 38128064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure dynamics after pubertal suppression with gonadotropin-releasing hormone analogs followed by estradiol treatment in transgender female adolescents: a pilot study.
    Perl L; Elkon-Tamir E; Segev-Becker A; Israeli G; Brener A; Oren A
    J Pediatr Endocrinol Metab; 2021 Jun; 34(6):741-745. PubMed ID: 33823098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Pressure Dynamics After Pubertal Suppression with Gonadotropin-Releasing Hormone Analogs Followed by Testosterone Treatment in Transgender Male Adolescents: A Pilot Study.
    Perl L; Segev-Becker A; Israeli G; Elkon-Tamir E; Oren A
    LGBT Health; 2020; 7(6):340-344. PubMed ID: 32735503
    [No Abstract]   [Full Text] [Related]  

  • 18. A Longitudinal Study of Features Associated with Autism Spectrum in Clinic Referred, Gender Diverse Adolescents Accessing Puberty Suppression Treatment.
    Russell I; Pearson B; Masic U
    J Autism Dev Disord; 2021 Jun; 51(6):2068-2076. PubMed ID: 32936414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for pubertal suspension and gender reassignment for transgender adolescents.
    Hembree WC
    Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):725-32. PubMed ID: 22051008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescents with gender dysphoria.
    Cohen-Kettenis PT; Klink D
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):485-95. PubMed ID: 26051304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.